Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (Nature Medicine, (2020), 26, 10, (1549-1556), 10.1038/s41591-020-1008-z)

2Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the version of this article initially published, the affiliation provided for author Matteo Giovanni Della Porta (37Cancer Center, Humanitas Research Hospital & Humanitas University, Milan, Italy) was incorrect, and a second affiliation was missing. The correct affiliations are as follows (with subsequent affiliations renumbered accordingly): 37Humanitas Clinical and Research Center–IRCCS, Humanitas Cancer Center, Milan, Italy. 38Department of Biomedical Sciences, Humanitas University, Milan, Italy. The errors have been corrected in the HTML and PDF versions of the article.

Cite

CITATION STYLE

APA

Bernard, E., Nannya, Y., Hasserjian, R. P., Devlin, S. M., Tuechler, H., Medina-Martinez, J. S., … Papaemmanuil, E. (2021, March 1). Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (Nature Medicine, (2020), 26, 10, (1549-1556), 10.1038/s41591-020-1008-z). Nature Medicine. Nature Research. https://doi.org/10.1038/s41591-021-01253-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free